Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: An open-label pilot study with five newly diagnosed patients

Clinical Rheumatology

Volumn 27, Issue 1, 2008, Pages 85-89

  Tanaka, Hiroshi ^a   Tsugawa, Koji ^a   Oki, Eishin ^a   Suzuki, Koichi ^a   Ito, Etsuro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Induction therapy; Lupus nephritis; Mizoribine; Mizoribine intermittent pulse therapy; Systemic lupus erythematosus

Indexed keywords

CREATININE; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE;

ADOLESCENT; AMENORRHEA; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPLEMENT HEMOLYSIS TEST; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERURICEMIA; INFECTION; KIDNEY BIOPSY; LEUKOPENIA; LIVER DYSFUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; OPEN STUDY; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS RASH;

ADOLESCENT; BIOPSY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDNISOLONE; PULSE THERAPY, DRUG; RIBONUCLEOSIDES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 36549028850     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0635-9     Document Type: Article

References (18)

1. Lai KN, Tang SC, Mok CC (2005) Treatment for lupus nephritis: A revisit. Nephrology (Carlton) 10:180-188
2. Yokota S (2002) Mizoribine: Mode of action and effects in clinical use. Pediatr Int 44:196-198
3. Hirayama K, Kobayashi M, Hashimoto Y et al (2004) Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis. Am J Kidney Dis 44:57-63
4. Tanaka H, Tsugawa K, Tsuruga K et al (2004) Mizoribine for the treatment of lupus nephritis in children and adolescents. Clin Nephrol 62:412-417
5. Yumura W, Suganuma K, Uchida K et al (2005) Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Clin Nephrol 64:28-34
6. Sonda K, Takahashi K, Tanabe K et al (1996) Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 28:3643-3648
7. Takahashi S, Wakui H, Gustafsson JA et al (2000) Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 274:87-92
8. Tanaka H, Suzuki K, Nakahata T et al (2003) Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 60:390-394
9. Tanaka H, Tsugawa K, Suzuki K et al (2006) Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis. Pediatr Nephrol 21:962-966
10. Kawasaki Y, Hosoya M, Kobayashi S et al (2005) Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome. Nephrol Dial Transplant 20:2243-2247
11. Tanaka H, Tsugawa K, Nakahata T et al (2005) Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome. Tohoku J Exp Med 205:87-91
12. Tanaka H, Tateyama T, Waga S (2001) Metylprednisolone pulse therapy in Japanese children with severe lupus nephritis. Pediatr Nephrol 16:817-819
13. Mosca M, Bencivelli W, Vitali C et al (2000) The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 9:445-450
14. Tanaka H, Oki Es, Tsugawa K et al (2007) Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: Report of two patients. Nephrology 12 (in press)
15. Yumura W, Uchida K, Kawashima A et al (1999) Evaluation of plasma concentration of mizoribine as an immunosuppressive agent in lupus nephritis patients. Jin To Toseki 47:705-708 (in Japanese)
16. Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children - a review of 167 patients. Pediatrics 94:335-340
17. Lehman TJ, Onel K (2000) Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136:243-247
18. Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158-166